Protego Biopharma

Protego Biopharma is a small biotechnology company located in San Diego, California. With 21 employees, the company focuses its efforts on the discovery and development of novel therapeutics. Protego Biopharma specializes in developing small-molecule drugs designed to reprogram protein folding for the treatment of a range of diseases. Their approach builds upon the proven pharmacological chaperone strategy demonstrated by tafamidis, the first commercially available treatment for systemic amyloidosis. Utilizing advancements in biology, chemical biology, biomarkers, structural biology, and computation, Protego Biopharma aims to expand their therapeutic reach and create cutting-edge treatments. The company boasts a team of experienced experts in the discovery and development of small molecule pharmacological chaperones and protein homeostasis modulators. Their collaborative efforts are supported by world-class investors and partners who share their commitment to developing innovative therapies. For more information, please visit Protego Biopharma's website at protectbiopharma.com.